| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 20 |
| 1 | OCTREOTIDE ACETATE | 16 |
| 2 | ADALIMUMAB | 5 |
| 3 | APIXABAN | 5 |
| 4 | ETOPOSIDE | 5 |
| 5 | FUROSEMIDE | 5 |
| 6 | IBUPROFEN | 5 |
| 7 | LUTETIUM LU 177 DOTATATE | 5 |
| 8 | RISANKIZUMAB-RZAA | 5 |
| 9 | ACETAMINOPHEN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRODALUMAB | 4 | 0.0019 |
| 1 | OSILODROSTAT | 3 | 0.0014 |
| 2 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 3 | DISULFIRAM | 1 | 0.0009 |
| 4 | LUTETIUM LU 177 DOTATATE | 5 | 0.0009 |
| 5 | ACITRETIN | 4 | 0.0008 |
| 6 | ALDESLEUKIN | 1 | 0.0008 |
| 7 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 8 | SELUMETINIB | 1 | 0.0006 |
| 9 | OCTREOTIDE ACETATE | 16 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 4 | 0.0019 |
| 1 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 4 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 8 | Interleukin-23 Antagonist [EPC] | 7 | 0.0001 |
| 9 | Topoisomerase Inhibitor [EPC] | 5 | 0.0001 |